Lecanemab for Alzheimer’s in real life: blood markers moved first, brain swelling was rare
A real-world study of 181 people with Alzheimer's in China, published in October 2026 in Alzheimer's & Dementia, found that responses to lecanemab emerged at 6 months, mostly in early disease, and…
